Full-Time

Vice President

Global Value, Access & Distribution

Confirmed live in the last 24 hours

Cytokinetics

Cytokinetics

201-500 employees

Develops drugs for muscle function diseases

Biotechnology

Compensation Overview

$330,000 - $370,000Annually

Senior, Expert

San Bruno, CA, USA

Required Skills
Sales
Public Policy
Marketing
Data Analysis
Requirements
  • BS/BA degree; master's degree or higher preferred.
  • Minimum of fifteen (15) years with biopharmaceutical market access experience, including direct healthcare systems experience in a health plan environment including significant experience in network development, provider/third party payer contracting, value-based reimbursement, and the development of ACOs; in-depth knowledge of managed care regulations; solid understanding of health plan operations and how they think and make decisions.
  • Established relationships with several key national and regional payers; ability to easily make calls to discuss market needs and opportunities.
  • Demonstrated knowledge of managed care lines of business, including Medicare, state Medicaid and Commercial HMO products; Clear understating of Medicare and Medicaid public policy as it relates to quality measures and reimbursement.
  • Launch experience is a must, cardiology experience is highly preferred but not required
  • Commutable to either South San Francisco or Radnor, PA is required with in office expectation of at least 3 days per week.
  • Ability to travel ~35% required.
Responsibilities
  • Lead the Global Value and Access functions at Cytokinetics to support reimbursement, maximize patient access, revenue, and profitability.
  • Support the launch of our first and subsequent products to achieve our growth objectives.
  • Work collaboratively with EU Leadership Team to develop global pricing and reimbursement strategies and align them with EU stakeholders.
  • Consult with EU Leaders to determine the EU launch sequence, considering international reference pricing.
  • Work with sales, marketing, and finance teams, recommend and execute a US managed care strategy for payer and key channels, including commercial insurers, Pharmacy Benefit Managers (PBMs), Integrated Health Networks (IHN), State Medicaid, Medicare, and Federal VA/DoD channels.
  • Oversee our Trade and Distribution strategy. Collaborating with cross functional team members as well as managing day to day activities with wholesalers, distributors, and pharmacies.
  • Supervise global HEOR function while collaborating with Medical Affairs to inform data generation plans to strengthen the product value dossier including compelling and credible information for the US, and global payer customers.
  • Serve as a key stakeholder on US pricing committee and make recommendations to ensure alignment with all key stakeholders as it relates to contracting, rebating, to price adjustments, best price, and other related elements.
  • Work cross functionally to ensure profitable and complaint contracts are successfully executed. This includes overseeing all contracting analytics and outcomes evaluations.
  • Monitor trends and potential coverage and reimbursement issues, existing and emerging government and payer policies, competitive pricing and contracting strategies, and potential barriers to provider and patient access.
  • Proactively meet with senior leadership at key U.S. payers to identify opportunities for broader collaboration and partnership, including both regional and national health plans.
  • Maintain ongoing relationships with U.S. payers, monitor performance of new contracts and pull-through.
  • Develop and oversee implementation of U.S. managed care strategy, analytics and contracting initiatives that will drive above market performance.

Cytokinetics is a late-stage biopharmaceutical company focused on developing small molecule muscle activators and inhibitors to address impaired muscle function in conditions such as heart failure, hypertrophic cardiomyopathy, and neuromuscular diseases. The company's main technologies involve engineering drug candidates to impact muscle function and contractility, with the goal of discovering, developing, and commercializing potential treatments for debilitating diseases.

Company Stage

IPO

Total Funding

$1.2B

Headquarters

South San Francisco, California

Founded

1998

Growth & Insights
Headcount

6 month growth

0%

1 year growth

4%

2 year growth

41%